High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma

AIMS: To evaluate the clinical significance of coatomer protein complex subunit beta 2 (COPB2) in patients with glioma using a bioinformatics analysis. METHODS: Oncomine, GEO, and The Cancer Genome Atlas databases were used to examine the COPB2 transcript levels in glioma tissues. Gene expression pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yan, Wang, Xuan, Huang, Xing, Li, Xu‐Dong, Cheng, Kai, Yu, Hao, Zhou, Yu‐Jie, Lv, Peng, Jiang, Xiao‐Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081167/
https://www.ncbi.nlm.nih.gov/pubmed/31710183
http://dx.doi.org/10.1111/cns.13254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081167/
https://www.ncbi.nlm.nih.gov/pubmed/31710183
http://dx.doi.org/10.1111/cns.13254

Ejemplares similares